Continuous Postoperative Monitoring Reduces Duration of Oxygen Desaturation
via HealthDayWEDNESDAY, April 1, 2026 -- Continuous monitoring after noncardiac surgery is associated with a significant reduction in the duration of oxygen saturation less than 90 percent, according to a study published online March 26 in JAMA Network Open.
Ashish K. Khanna, M.D., from Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues examined whether continuous unblinded monitoring of vital signs would decrease blood pressure, heart rate, and oxygen saturation abnormalities compared with intermittent monitoring in patients recovering from noncardiac surgery in a crossover randomized cluster trial in two postoperative hospital wards. One ward was randomized to an initial month of unblinded or clinician-blinded continuous vital sign monitoring and then alternated at four-week intervals for one year, and the other ward used the alternate monitoring approach. Of the 798 patients, 404 were assigned to continuous monitoring and 394 to intermittent monitoring.
The researchers found that in continuously monitored patients, the duration of oxygen saturation less than 90 percent was reduced by approximately 30 minutes over 48 hours of monitoring time (70.8 versus 103.5 minutes; geometric means ratio, 0.86). No significant reductions were seen in hypotension or tachycardia durations. The groups had a similar number of interventions, with about half in each group receiving new oxygen therapy.
"This study provides an important push for the worldwide surgical and perioperative community," Khanna said in a statement. "Continuous wearable monitoring is no longer experimental. It's achievable, impactful, and ready for broader adoption."
Two authors disclosed ties to the biopharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-02 01:56
Read more
- Collagen Supplements Beneficial for Dermal, Bone, Musculoskeletal Health
- Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
- New COVID 'Cicada' Variant Is Spreading
- AHA: High Blood Pressure in Young Adulthood Tied to Higher Risk for Cardiovascular Events in Midlife
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- Recommendations Developed for Faltering Weight in Children
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions